Ferric carboxymaltose and its application in iron deficiency anemia
WANG Fang-hai
ZHAO Wei
CHEN Jian-fang
TANG Wei-fang
QIN Yong
Abstract：Iron deficiency anemia (IDA) is the most common nutrient deficiency in the world and mainly treated with chalybeate.Although oral iron was initially used with its inexpensive and easy application,the treatment is not satisfactory at present.Intravenous iron could remedy the weakness of oral iron,like poor absorption,slower effect,adverse reactions and worse compliance.New generations of intravenous iron appear continuously in recent years.Ferric carboxymaltose can meet the clinical requirement of large dose iron with short infusion time,which is the most prominent intravenous iron with bright market prospects.In this paper,we summarized the information of basic physical and chemical properties,synthetic methods,metabolic mechanism,clinical research,international marketing and domestic drug registration of the ferric carboxymaltose,providing a reference for the research and development as well as popularization and promotion of ferric carboxymaltose in China.
Keywords：ferric carboxymaltoseintravenous ironiron deficiency anemia
Publication Date：2017-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：5( 1011-1015 )